Latest Developments in Global Sarilumab Market

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
back-icon

Back to Report
Home Pharmaceutical Global Sarilumab Market Latest Developments
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Sarilumab Market

  • Pharmaceutical
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
Buy Now Buy Now Request for Sample Request for Sample
Nucleus Nucleus

  • In June 2024, The US Food and Drug Administration (FDA) has approved Kevzara (sarilumab), developed by Sanofi and Regeneron, for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients who weigh at least 63kg

Browse Related Pages

Banner